Minimum effective dose of chenic acid for gallstone patients: reduction with bedtime administration and low cholesterol diet.
Open Access
- 1 April 1982
- Vol. 23 (4) , 280-284
- https://doi.org/10.1136/gut.23.4.280
Abstract
The aim of this study was to determine whether bedtime administration and a low cholesterol diet reduce the minimum effective dose of chenodeoxycholic (chenic) acid, defined as the dose giving a mean cholesterol saturation index of 0.8. Dose response studies were carried out in 10 patients with radiolucent gallstones in a functioning gallbladder during three different treatment regimens. On each regimen, all patients received three different doses of chenodeoxycholic acid in random order for one month each. Bedtime chenic acid plus a low cholesterol diet gave the greatest reduction in saturation index. A significant dose/response relationship was found on each regimen. On the conventional regimen of mealtime chenic acid, the minimum effective dose was 14 mg/kg/day; on bedtime chenic acid it was 12.4 mg/kg/day; and on bedtime chenic acid plus low cholesterol diet it was further reduced to 8.4 mg/kg/day (p less than 0.01). There was a dose-related increase in bowel frequency, which was absent at 10.6 mg/kg/day and below. We conclude that administration of chenic acid at bedtime with a low cholesterol diet enables the minimum effective dose for gallstone dissolution to be approximately halved, thus preventing diarrhoea and reducing the cost of treatment.This publication has 17 references indexed in Scilit:
- Optimal timing of doses of chenic acid in patients with gall stones.BMJ, 1979
- Low-cholesterol diet: enhancement of effect of CDCA in patients with gall stones.BMJ, 1978
- URSODEOXYCHOLIC ACID TREATMENT OF GALLSTONESThe Lancet, 1977
- Enzymatic determination of cholesterol in bileClinica Chimica Acta; International Journal of Clinical Chemistry, 1975
- Chenodeoxycholic Acid Treatment of GallstonesNew England Journal of Medicine, 1975
- EFFECT OF DIFFERENT DOSES OF CHENODEOXYCHOLIC ACID ON BILE-LIPID COMPOSITION AND ON FREQUENCY OF SIDE-EFFECTS IN PATIENTS WITH GALLSTONESThe Lancet, 1974
- Cholesterol Solubility in Bile. EVIDENCE THAT SUPERSATURATED BILE IS FREQUENT IN HEALTHY MANJournal of Clinical Investigation, 1973
- GALLSTONE DISSOLUTION IN MAN USING CHENODEOXYCHOLIC ACIDThe Lancet, 1972
- The solubility of cholesterol in aqueous solutions of bile salts and lecithinZeitschrift Fur Ernahrungswissenschaft, 1971
- The physicochemical basis of cholesterol gallstone formation in manJournal of Clinical Investigation, 1968